Results 131 to 140 of about 17,248,582 (189)

Comparative evaluation of USP II, USP IV, TIM-2, and the dynamic colon model as surrogates for human colonic drug dissolution.

RSC Pharm
Khandelwal K, Jones E, O'Farrell C, Batchelor HK.   +3 more
europepmc   +1 more source

Influence of Core and Membrane Composition on Drug Release from MCC/Isomalt-Based Matrix Pellets in Biorelevant Osmolarity Media. [PDF]

Pharmaceutics
Fleck C, Aghrbi I, Vlahovic K, Erdő F, Laki AJ, Kállai-Szabó N, Antal I, Lengyel M.   +7 more
europepmc   +1 more source

Reduced-Resistances Model for Enhanced Drug Permeation via a Solubilizing Receiver Medium: A Mechanistic Study with Hollow Fiber Membranes. [PDF]

Mol Pharm
Murray JD, Patel RP, Bennett-Lenane H, O'Dwyer PJ, Griffin BT, Polli JE.   +5 more
europepmc   +1 more source

From simulation to application: enhancing preclinical evaluation of dissolvable microarray patches through PBPK modelling. [PDF]

Drug Deliv Transl Res
Railic M, de Witte WEA, Schaller S, Agboola ST, Sartawi Z, Faisal W, Elkhashab M, Crean A, Vucen S.   +8 more
europepmc   +1 more source

Reversible Photoswitching of Donor-Acceptor Stenhouse Adducts in Water. [PDF]

J Am Chem Soc
Blandón-Cumbreras FG, Jurtík M, Závodná A, Janovský P, Rouchal M, Vícha R, Pischel U.   +6 more
europepmc   +1 more source

Physiologically Based Biopharmaceutics Modelling-Best Scientific Practices to Define Drug Product Performance, Latest Regulatory and Industry Perspectives: Workshop Summary Report. [PDF]

Pharmaceutics
McAllister M, Mistry N, Pepin X, Cole S, Tannergren C, Stamatopoulos K, Engman H, Moir A, Litou C, Gavins F, Arora S, Malamatari M, Guimarães M, Ravi A, Fotaki N, Dodd L, Holte Ø, Butler J, Dickinson PA, Popkin M, Butler A, NiOgain O, Holmstock N, Mackie C.   +23 more
europepmc   +1 more source

TILLÄMPNING AV BIORELEVANT MEDIA : En litteraturstudie med fokus på betydelsen av biorelevant media för simulering av läkemedelsfrisättning in vivo

, 2021
openaire   +1 more source

Integrating In Vitro Dissolution and Physiologically Based Pharmacokinetic Modeling for Generic Drug Development: Evaluation of Amorphous Solid Dispersion Formulations for Tacrolimus. [PDF]

Pharmaceutics
Karakitsios E, Angelerou MF, Kapralos I, Tsakiridou G, Kalantzi L, Dokoumetzidis A.   +5 more
europepmc   +1 more source

Pre-Formulation Studies of Lipid-Based Formulation Approach for a Poorly Water-Soluble Biopharmaceutics Classification System Class II Model Drug: Bosentan. [PDF]

Turk J Pharm Sci
Yılmaz Usta D, Teksin ZŞ.
europepmc   +1 more source

The fourth controlled release society workshop on oral peptide administration. [PDF]

Front Drug Deliv
Brayden DJ, Buckley ST, Lewis AL.
europepmc   +1 more source